Detalles de la búsqueda
1.
Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.
Nat Genet
; 39(5): 655-60, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17417639
2.
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial.
Breast Cancer Res Treat
; 150(2): 279-88, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25721604
3.
Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice.
Genes Chromosomes Cancer
; 53(3): 228-39, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24311521
4.
Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer - results from the HER-OS patient registry.
BMC Cancer
; 14: 806, 2014 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-25371387
5.
Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group.
Cancers (Basel)
; 15(5)2023 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900372
6.
High level of Ets-related gene expression has high specificity for prostate cancer: a tissue microarray study of 11 483 cancers.
Histopathology
; 61(3): 445-53, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22463702
7.
Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.
Oncology
; 82(6): 305-12, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22555284
8.
Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.
BMC Cancer
; 12: 140, 2012 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-22475274
9.
Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Breast Cancer Res Treat
; 129(2): 347-60, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20972617
10.
Management of patients with brain metastases receiving trastuzumab treatment for metastatic breast cancer.
Onkologie
; 34(6): 304-8, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21625183
11.
Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer.
Breast Cancer Res Treat
; 120(2): 481-9, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20130985
12.
Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell lines.
Oncol Rep
; 22(1): 177-83, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19513521
13.
Expression and prognostic value of L1-CAM in breast cancer.
Oncol Rep
; 22(5): 1109-17, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19787228
14.
Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas.
Anticancer Res
; 29(1): 183-9, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19331149
15.
Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: a phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy.
BMC Cancer
; 8: 62, 2008 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-18302747
16.
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.
Clin Cancer Res
; 13(3): 920-8, 2007 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17289886
17.
Continuing with letrozole offers greater benefits.
J Cancer Res Clin Oncol
; 133(7): 445-53, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17226047
18.
Prognostic and predictive impact of soluble epidermal growth factor receptor (sEGFR) protein in the serum of patients treated with chemotherapy for metastatic breast cancer.
Anticancer Res
; 26(2B): 1479-87, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16619561
19.
Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity.
Clin Cancer Res
; 11(10): 3678-85, 2005 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15897564
20.
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.
J Natl Cancer Inst
; 94(2): 116-28, 2002 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-11792750